pylori infection, which prevents NLRP3 from being activated by blocking the TLR/NF-B-dependent signaling pathway
The most common question from patients considering GLP-1 therapy is which medication produces the best results
Therefore, patients who may be affected by this action should be observed carefully
doi: 10.1080/07380577.2021.1953205
Seek urgent medical attention if you experience: Severe or persistent abdominal pain, particularly if it radiates to your back this may indicate pancreatitis or gallbladder disease, which have been associated with GLP-1 receptor agonist class medicines [16] [17] Persistent vomiting or an inability to keep fluids down, which may lead to dehydration Yellowing of the skin or eyes, or dark urine (possible signs of liver or gallbladder problems) Signs of a serious allergic reaction, such as facial swelling, difficulty breathing, or a widespread rash Contact your prescriber or trial team if: Hunger is severe, persistent, and significantly interfering with your ability to adhere to the treatment plan You are experiencing rapid or unexpected weight gain despite taking the medication as prescribed You notice symptoms that may suggest hypoglycaemia (low blood sugar), such as shakiness, sweating, confusion, or palpitations
PMID 8598105.
